In this episode, we unpack a groundbreaking study that could reshape how we think about mental health care. For the first time, a fully automated generative AI chatbot—Therabot—has been rigorously tested in a randomized controlled trial to treat depression, anxiety, and eating disorders. The results? Promising, and possibly game-changing.

Topics Covered:

• How Therabot was developed and clinically validated

• Key findings from the NEJM AI-published study

• The significance of small but meaningful improvements in mental health symptoms

• Understanding therapeutic alliance with AI: can bots build trust?

• Implications for access, scalability, and the future of digital mental health care

• Ethical considerations and what still needs to be addressed

Credits:
Production: MedShake Studio
Host: Anca Petre

✔ Stay connected and learn more:

• LinkedIn: linkedin.com/in/ancapetre

• Website: www.ancapetre.com & www.medshake-studio.com

• Email: anca@medshakestudio.com

More about the podcast:
Every week, I dive into the most transformative trends at the intersection of technology and healthcare. From AI-driven breakthroughs in diagnostics to the role of blockchain in securing health data, from decentralized science (DeSci) to NFT-powered health innovation, and from gamified fitness to the potential of digital twins, I’m here to make complex topics simple, accessible, and exciting.

Hosted on Ausha. See ausha.co/privacy-policy for more information.